I agree what you stated may be what some retails could be thinking. However my 2c is how difficult the trials have been and how far they have come especially with stellar data.
RT002 market being largely affluent consumer-centric, ensuring there is a flawless and highly differentiated product is the key and co has delivered.
With regard to financing, on flip side I see this as a strength when they negotiate on a partnership deal for commercialization. Finally with additional cash, EV just got more compelling for a highly de-risked P3 product company.
My mild surprise is JPM are not one of the bookies; guess they were content with good breakfast on Revance‘ cost at JPM19 :)
P.S: Didn’t JPM increase their stake in Revance not too long ago ?
News 
Market Data 
Discover 
